
Adventris Pharmaceuticals YC Application
Adventris Pharmaceuticals went through Y Combinator in the Winter 2023 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2023
- Industry
- HealthcareDrug Discovery and Delivery
- Team size
- 7
- Status
- Active
- Launched
- 2023
Founders
Jen HerbachFounder
William CollisFounder
Mark YarchoanFounder
What Adventris Pharmaceuticals does
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually - preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at
Adventris Pharmaceuticals's YC application, reconstructed
Y Combinator application
Adventris Pharmaceuticals, Winter 2023 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Adventris Pharmaceuticals
Adventris makes cancer vaccines
We make cancer vaccines designed to target oncogenes that typically evade immune detection. Our first product is an "off-the-shelf" vaccine targeting KRAS, which is the most common cancer oncogene. Our platform aims to enable vaccines that could prevent many cancers before they develop.
We live in Baltimore, MD and plan to keep the company based here after YC.
Baltimore has strong biotech resources and is our home. Staying here keeps us close to our team and research partners.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Adventris Pharmaceuticals YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Adventris Pharmaceuticals's public data (launch notes, founder backgrounds, product description). It shows how a company like Adventris Pharmaceuticals would present itself to YC, not the text they submitted.
What YC batch was Adventris Pharmaceuticals in?
Adventris Pharmaceuticals was part of the Y Combinator Winter 2023 batch.
Who founded Adventris Pharmaceuticals?
Adventris Pharmaceuticals was founded by Jen Herbach, William Collis, Mark Yarchoan.
What does Adventris Pharmaceuticals do?
Adventris makes cancer vaccines
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Adventris Pharmaceuticals's application, and every other YC batch, is in YC Insights.